Used primarily as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of bioactive molecules with potential antipsychotic, antidepressant, or antihistaminic properties. Its structure supports binding to central nervous system receptors, making it valuable in medicinal chemistry research. Also employed in the preparation of novel piperazine-based derivatives for structure-activity relationship (SAR) studies. Additionally, it serves as a building block in the creation of fluorinated organic compounds, where the trifluoromethyl group enhances metabolic stability and lipophilicity in drug candidates.